UnitedHealth Group (NYSE:UNH) Price Target Cut to $550.00

UnitedHealth Group (NYSE:UNHGet Rating) had its price objective dropped by stock analysts at UBS Group from $590.00 to $550.00 in a report released on Wednesday, The Fly reports. The brokerage presently has a “neutral” rating on the healthcare conglomerate’s stock. UBS Group’s target price would indicate a potential upside of 13.55% from the company’s previous close.

Other analysts have also recently issued research reports about the stock. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $569.00 to $615.00 and gave the company a “buy” rating in a research report on Tuesday, October 18th. Raymond James cut shares of UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price objective on the stock. in a research report on Monday, November 21st. Royal Bank of Canada increased their price objective on shares of UnitedHealth Group from $588.00 to $592.00 and gave the stock an “outperform” rating in a research report on Monday, October 17th. Morgan Stanley reissued an “overweight” rating and set a $587.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, November 23rd. Finally, Loop Capital increased their price objective on shares of UnitedHealth Group from $575.00 to $590.00 in a research report on Tuesday. Three investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $599.28.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $484.36 on Wednesday. The company has a quick ratio of 0.82, a current ratio of 0.77 and a debt-to-equity ratio of 0.67. UnitedHealth Group has a twelve month low of $445.73 and a twelve month high of $558.10. The stock has a market cap of $452.56 billion, a price-to-earnings ratio of 22.86, a P/E/G ratio of 1.35 and a beta of 0.73. The company’s fifty day moving average is $519.94 and its 200 day moving average is $524.48.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, beating analysts’ consensus estimates of $5.17 by $0.17. The business had revenue of $82.79 billion for the quarter, compared to analysts’ expectations of $82.53 billion. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The business’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $4.48 earnings per share. Sell-side analysts forecast that UnitedHealth Group will post 24.82 EPS for the current year.

Insider Activity

In other news, EVP Erin Mcsweeney sold 450 shares of the stock in a transaction that occurred on Wednesday, December 7th. The shares were sold at an average price of $542.30, for a total transaction of $244,035.00. Following the completion of the transaction, the executive vice president now directly owns 8,736 shares of the company’s stock, valued at approximately $4,737,532.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.40% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Wealthstream Advisors Inc. raised its holdings in UnitedHealth Group by 4.4% in the 2nd quarter. Wealthstream Advisors Inc. now owns 452 shares of the healthcare conglomerate’s stock valued at $232,000 after buying an additional 19 shares during the period. CoreCap Advisors LLC boosted its holdings in UnitedHealth Group by 0.5% in the second quarter. CoreCap Advisors LLC now owns 4,217 shares of the healthcare conglomerate’s stock valued at $2,166,000 after purchasing an additional 19 shares in the last quarter. Elgethun Capital Management boosted its holdings in UnitedHealth Group by 0.3% in the second quarter. Elgethun Capital Management now owns 6,577 shares of the healthcare conglomerate’s stock valued at $3,369,000 after purchasing an additional 19 shares in the last quarter. Hollencrest Capital Management boosted its holdings in UnitedHealth Group by 0.8% in the third quarter. Hollencrest Capital Management now owns 2,337 shares of the healthcare conglomerate’s stock valued at $1,180,000 after purchasing an additional 19 shares in the last quarter. Finally, Smith Salley & Associates boosted its holdings in UnitedHealth Group by 0.7% in the third quarter. Smith Salley & Associates now owns 2,873 shares of the healthcare conglomerate’s stock valued at $1,451,000 after purchasing an additional 19 shares in the last quarter. 86.31% of the stock is owned by institutional investors.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

The Fly logo

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.